section name header

Information

Microbiology, Epidemiology, and Pathogenesis !!navigator!!

Botulism is a paralytic disease caused by neurotoxins elaborated by Clostridium botulinum, an anaerobic spore-forming gram-positive bacterium, as well as a few other toxigenic Clostridium spp.

Clinical Manifestations !!navigator!!

Botulism occurs naturally as four syndromes: (1) food-borne illness; (2) wound infection; (3) infant botulism; and (4) adult intestinal toxemia, which is similar to infant botulism. The disease presents as symmetric cranial-nerve palsies (diplopia, dysarthria, dysphonia, ptosis, facial paralysis, and/or impaired gag reflex) followed by symmetric, descending flaccid paralysis that may progress to respiratory failure and death. Constipation due to paralytic ileus is nearly universal, and fever is usually absent.

  • Food-borne botulism occurs 8-36 h (or up to 10 days, depending on the dose) after ingestion of food contaminated with toxin and ranges in severity from mild to fatal (within 24 h). Nausea, vomiting, and abdominal pain may precede or follow the onset of paralysis.
  • Wound botulism occurs when spores contaminate wounds and germinate, with an incubation period of 4-17 days.
  • In infant botulism and adult intestinal toxemia, spores germinate in the intestine and produce toxin, which is absorbed and causes illness. This form in infants has been associated with contaminated honey; thus, honey should not be fed to children <12 months of age. Adult pts typically have some anatomic or functional bowel abnormality or have a bowel flora disrupted by recent antibiotic use.

Diagnosis !!navigator!!

The clinical symptoms suggest the diagnosis. The definitive test is the demonstration of the toxin in clinical specimens (serum, stool, gastric aspirates, wound material) and food samples.

  • When results are not readily available, clinical decisions (e.g., to administer botulinum antitoxin) need to be made in their absence.
  • This test may yield a negative result even if the pt has botulism, particularly if specimens are collected >7 days after symptom onset; additional tests (e.g., culture of stool or wound material for toxigenic clostridia) may be necessary.

Treatment: Botulism

  • The mainstays of treatment are meticulous supportive care and immediate administration of botulinum antitoxin—the only specific treatment.
    • - Adults are given an equine antitoxin available through the CDC (770-488-7100); infant botulism is treated with a human-origin antitoxin (licensed as BabyBIG®) available through the California Department of Public Health (510-231-7600).
    • - In wound botulism, suspect wounds and abscesses should be cleaned, debrided, and drained promptly, and antimicrobial therapy (e.g., with a penicillin) should be guided by clinical judgment, as its clinical efficacy has not been established and may result in increased circulating toxin from lysis of bacteria.

Prognosis !!navigator!!

Botulinum antitoxin limits progression of illness by neutralizing free toxin without affecting paralysis that is already present. Toxin binding is irreversible, but nerve terminals do regenerate.


Outline

Outline

Section 7. Infectious Diseases